Profile for Fate Therapeutics, Inc. (FATE)
« Back to company indexFATE Chatter Timeline
Stock Ticker for FATE
Most Active Tweeters for FATE
| User | Tweets |
|---|---|
| @tribepublic | 5 |
| @JasonHolman5 | 5 |
| @VistaPResearch | 5 |
| @ConsumerFeed | 4 |
| @dispatchtribune | 4 |
Recent Tweets for FATE
 |
@ThisLincolnian $2.02 Million in Sales Expected for Fate Therapeutics $FATE This Quarter https://t.co/b13nWx85FU April 23rd 2018, 6:04am |
 |
@dispatchtribune Somewhat Positive News Coverage Somewhat Unlikely to Impact Fate Therapeutics $FATE Share Price https://t.co/OWk0wXWk9D April 23rd 2018, 3:04am |
 |
@EnterpriseLeade Somewhat Positive News Coverage Somewhat Unlikely to Affect Fate Therapeutics $FATE Stock Price https://t.co/Ht5n5tC11I April 23rd 2018, 3:04am |
 |
@storminvestor $2.02 Million in Sales Expected for Fate Therapeutics $FATE This Quarter https://t.co/6oykVfY5WC April 23rd 2018, 3:04am |
 |
@TranscriptDaily Zacks: Analysts Anticipate Fate Therapeutics $FATE Will Announce Quarterly Sales of $2.02 Million https://t.co/OgR3Znbjs4 April 23rd 2018, 3:04am |
 |
@JasonHolman5 $FATE ... really like the promise of their OTS approach leveraging induced pluripotent stem cell lines. https://t.co/YkHV7SRK5r April 22nd 2018, 6:04pm |
 |
@registrarjourn Brokerages Set Fate Therapeutics $FATE Target Price at $16.17 https://t.co/RfrPPXVeM6 April 21st 2018, 11:04pm |
|
@ThisLincolnian -$0.22 EPS Expected for Fate Therapeutics $FATE This Quarter https://t.co/3wD7YT4WWV April 21st 2018, 3:04pm |
 |
@AmericanBanking -$0.22 EPS Expected for Fate Therapeutics $FATE This Quarter https://t.co/YFR52PmLZs #stocks April 21st 2018, 3:04pm |
 |
@VistaPResearch RT @tribepublic: Fate Therapeutics $FATE spoke with #investors in Minneapolis today. Want to meet Fate Therapeutics in your City? Learn how… April 21st 2018, 11:04am |
 |
@ConsumerFeed Brokerages Set Fate Therapeutics $FATE Target Price at $16.17 https://t.co/zHriOQzIBh April 19th 2018, 6:04pm |
|
@ThisLincolnian Fate Therapeutics $FATE Receives $16.17 Average Price Target from Analysts https://t.co/Uy9JXk1xRv April 19th 2018, 6:04pm |
 |
@tribepublic Fate Therapeutics $FATE spoke with #investors in Minneapolis today. Want to meet Fate Therapeutics in your City? Le… https://t.co/Tarpla7G1Y April 19th 2018, 1:04pm |
 |
@thomaspan RT @ZorTrades: $FATE coling for a 2nd try https://t.co/GkxgtGJJn8 April 19th 2018, 10:04am |
 |
@ZorTrades $FATE coling for a 2nd try https://t.co/GkxgtGJJn8 April 19th 2018, 10:04am |
|
@VistaPResearch RT @tribepublic: Fate Therapeutics $FATE spoke with #investors in Chicago today. Want to meet Fate Therapeutics in your City? Learn how at… April 19th 2018, 12:04am |
|
@tribepublic Fate Therapeutics $FATE spoke with #investors in Chicago today. Want to meet Fate Therapeutics in your City? Learn… https://t.co/d6dLzsztgz April 18th 2018, 3:04pm |
 |
@365Investing RT @ZorTrades: $FATE swing of interest thru yday's high https://t.co/MRv4i9APtD April 18th 2018, 11:04am |
 |
@CaesarBiotech RT @JasonHolman5: https://t.co/Qa49rf1G9F $FATE updated Corp. Pres.,comprehensive. Pgms across both I-O&Immuno Reg,1st slide on APOLLO data… April 18th 2018, 9:04am |
|
@ZorTrades $FATE swing of interest thru yday's high https://t.co/MRv4i9APtD April 18th 2018, 7:04am |
 |
@OlympiaReport Fate Therapeutics $FATE Getting Somewhat Positive News Coverage, Study Shows https://t.co/1fu4LhIRzs April 18th 2018, 3:04am |
|
@dispatchtribune Fate Therapeutics $FATE Receives Coverage Optimism Score of 0.17 https://t.co/fNyDw0R0EH April 18th 2018, 3:04am |
 |
@rhoman1996 RT @upsidetrader: $FATE popped above downtrend last week, now flagging , looks 12.50-14.00 https://t.co/m2ApjzIiVu April 17th 2018, 8:04pm |
 |
@Abkon187 RT @AmyAtrade: $FATE long setup https://t.co/sg3KmIdnap April 17th 2018, 6:04pm |
 |
@AmyAtrade $FATE long setup https://t.co/sg3KmIdnap April 17th 2018, 5:04pm |
 |
@upsidetrader $FATE popped above downtrend last week, now flagging , looks 12.50-14.00 https://t.co/m2ApjzIiVu April 17th 2018, 1:04pm |
 |
@ok_trader $FATE watching tight pattern https://t.co/iHOWqcruvS April 17th 2018, 1:04pm |
|
@VistaPResearch RT @tribepublic: $FATE Fate Therapeutics Announces Off-the-Shelf CAR T-cell Cancer Immunotherapy to be Featured at 2018 AACR Annual Meeting… April 17th 2018, 12:04pm |
 |
@dailypoliticaln Brokerages Set Fate Therapeutics $FATE Target Price at $16.17 https://t.co/HeTz5YATgB April 17th 2018, 9:04am |
 |
@ledgerzette Fate Therapeutics $FATE Receives $16.17 Average Price Target from Analysts https://t.co/xfB1HTYoYv April 17th 2018, 9:04am |
 |
@bdailystocks $FATE $ 11.15 USD -0.39 (3.38%) - News Out on Fate Therapeutics https://t.co/ZVO8NPdMne April 16th 2018, 10:04pm |
 |
@Aesculapius1898 RT @JasonHolman5: From new $FATE Corp. Pres., although mgnt focusing on I-O oncology; am excited to see if they bring Toleracyte to the cli… April 16th 2018, 10:04pm |
 |
@Hall8Jack RT @BoerseGer: $FATE Presentation: https://t.co/ETZh8fM1RT Poster: https://t.co/n2HbsgHr43 April 16th 2018, 6:04pm |
|
@JasonHolman5 From new $FATE Corp. Pres., although mgnt focusing on I-O oncology; am excited to see if they bring Toleracyte to t… https://t.co/xqaLg5RBvs April 16th 2018, 5:04pm |
 |
@BoerseGer $FATE Presentation: https://t.co/ETZh8fM1RT Poster: https://t.co/n2HbsgHr43 April 16th 2018, 2:04pm |
 |
@danrocks4 FATE is number 58 for the largest percentage gain out of 100 stocks. $FATE Fate Therapeutics is up +18.78% in https://t.co/vFoalUC29K April 16th 2018, 2:04pm |
|
@tribepublic $FATE Fate Therapeutics Announces Off-the-Shelf CAR T-cell Cancer Immunotherapy to be Featured at 2018 AACR Annual… https://t.co/8YGmGk6mX8 April 16th 2018, 12:04pm |
 |
@Briefingcom $FATE: Fate Therapeutics to feature off-the-shelf CAR T-cell cancer immunotherapy, FT819, at 2018 AACR Annual... https://t.co/8ps2haySoB April 16th 2018, 11:04am |
|
@JasonHolman5 https://t.co/Qa49rf1G9F $FATE updated Corp. Pres.,comprehensive. Pgms across both I-O&Immuno Reg,1st slide on APOLL… https://t.co/efr09W3MtR April 16th 2018, 11:04am |
 |
@dhovekamp42 RT @JasonHolman5: https://t.co/JJCZu0hGGr $FATE presenting their OTS CAR-T FT819 for CD19 at AACR, really focusingbon the manufacturing pot… April 16th 2018, 11:04am |
|
@JasonHolman5 https://t.co/JJCZu0hGGr $FATE presenting their OTS CAR-T FT819 for CD19 at AACR, really focusingbon the manufacturi… https://t.co/btVGQAFAnG April 16th 2018, 11:04am |
 |
@BTLipschultz Interesting preclinical presentation from $fate for an off the shelf CAR T that will probably be in the IND stage in the next 12mths #aacr18 April 16th 2018, 10:04am |
 |
@CI4CC RT @BioStocks: $FATE Announces Off-the-Shelf CAR T-cell Cancer Immunotherapy to be Featured at #AACR18 https://t.co/b1VteDsukp April 16th 2018, 10:04am |
|
@CI4CC RT @odibro: $FATE Announces Off-the-Shelf CAR T-cell Cancer Immunotherapy to be Featured at #AACR18 https://t.co/G347y0Ym3v April 16th 2018, 10:04am |
 |
@odibro $FATE Announces Off-the-Shelf CAR T-cell Cancer Immunotherapy to be Featured at #AACR18 https://t.co/G347y0Ym3v April 16th 2018, 9:04am |
 |
@BioStocks $FATE Announces Off-the-Shelf CAR T-cell Cancer Immunotherapy to be Featured at #AACR18 https://t.co/b1VteDsukp April 16th 2018, 9:04am |
 |
@stockelite $FATE Fate Therapeutics Announces Off-the-Shelf CAR T-cell Cancer Immunotherapy to be Featured at 2018 AACR Annual… https://t.co/W0EcLijTtP April 16th 2018, 9:04am |
 |
@livetraderalrt $FATE 2.1m ago: Fate Therapeutics Announces Off-the-Shelf CAR T-cell Cancer Immunotherapy to be Featured at 2018 AA… https://t.co/HOwE3GFWoN April 16th 2018, 9:04am |
|
@BoerseGer $FATE Fate Therapeutics Announces Off-the-Shelf CAR T-cell Cancer Immunotherapy to be Featured at 2018 AACR Annual… https://t.co/W0O8BMKJBm April 16th 2018, 9:04am |
 |
@GNWLive Fate Therapeutics Announces Off-the-Shelf CAR T-cell Cancer Immunotherapy to be Featured at 2018 AACR $FATE https://t.co/kCrcrlw0GX April 16th 2018, 9:04am |
Contact © thinkBiotech LLC 2004 - 2018. All rights reserved.